This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Boston Scientific Inc (BSX)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -119.00M -121.00M -4.07B 0.00
Operating Gains/Losses -39.00M -29.00M -52.00M -798.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 53.00M -101.00M 37.00M 42.00M
(Increase) Decrease in Inventories -81.00M -7.00M 66.00M -54.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 620.00M -37.00M -131.00M -271.00M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 370.00M 300.00M 312.00M 46.00M
Other Non-Cash Items 137.00M 611.00M 4.58B 1.28B
Net Cash From Continuing Operations 1.27B 1.08B 1.26B 1.01B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.27B 1.08B 1.26B 1.01B
Sale of Property, Plant & Equipment 0.00 53.00M 16.00M 16.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -259.00M -245.00M -226.00M -304.00M
Acquisitions -474.00M -244.00M -378.00M 1.06B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -745.00M -475.00M -579.00M 769.00M
Issuance of Debt 810.00M 1.78B 371.00M 565.00M
Cash Used for Financing Activities
Issuance of Capital Stock 60.00M 74.00M 21.00M 21.00M
Repayment of Long-Term Debt -810.00M -1.79B -390.00M -1.81B
Repurchase of Capital Stock -125.00M -500.00M -600.00M -492.00M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -85.00M -160.00M -146.00M 0.00
Net Cash From Financing Activities -150.00M -596.00M -744.00M -1.72B
Effect of Exchange Rate Changes -4.00M -1.00M 3.00M -2.00M
Net Change in Cash & Cash Equivalents 370.00M 10.00M -60.00M 54.00M
BSX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

BSX Boston Scientific Inc

Chart of BSX

Analysts Ratings for BSX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 11 11 11
Moderate Buy 3 3 3 3
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1

BSX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs